We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Controlled Glucose Oscillations May Restore Insulin Production

By HospiMedica International staff writers
Posted on 08 Nov 2016
A new study suggests that administering controlled pulses of glucose via a microfluidic platform has the potential to reestablish normal insulin production and prevent type 2 diabetes.

Developed by researchers at Florida State University (FSU; Tallahassee, FL; USA), the Dual Oscillator Model (DOM) is a mathematical tool that can simulate experiments with the islets of Langerhans, small clusters of pancreatic cells that contain insulin-producing β-cells. More...
The DOM predicted that an oscillatory stimulus using pulses of glucose to the bloodstream has the potential to reactivate the insulin clock within β-cells that had been halted by exposure to excess glucose.

The researchers tested the hypothesis in a non-diabetic islets of Langerhans mice model. Using a specially engineered microfluidic device, they first delivered a high, steady, glucose stream; as expected, the insulin clock within the mouse islets was deactivated. But when controlled pulses of glucose were reapplied to the islets, the insulin clock was restarted. Moreover, when the flow of glucose followed a feedback loop simulating liver activity, the reactivated islets also recruited other islets to restart their insulin clock. The study was published on October 26, 2016, in PLOS Computational Biology.

“Microfluidics and mathematical modeling can be used together to gain new insights into the mechanisms for hormone secretion,” concluded senior author Richard Bertram, PhD, of the FSU department of mathematics and programs in neuroscience and molecular biophysics. “Our results have potential implications for enhancing insulin pulsatility, and therefore mitigating the development of type 2 diabetes.”

Pancreatic islets manage elevations in blood glucose level by secreting insulin into the bloodstream, governed by islet oscillations such as bursting electrical activity and periodic Ca2+ entry in β-cells. In healthy individuals, β-cells release regular pulses of insulin to restrict the amount of glucose released by the liver, as well as impel body tissues to absorb the glucose. However, in hyperglycemia, a hallmark of type 2 diabetes, the excess glucose suppresses the "inner clock" of β-cells that controls the rhythm of insulin pulses, reducing insulin production.

Related Links:
Florida State University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.